lifeway foods - LWAY
LWAY
Close Chg Chg %
23.89 0.11 0.46%
Closed Market
24.00
+0.11 (0.46%)
Volume: 13.26K
Last Updated:
Dec 24, 2025, 1:00 PM EDT
Company Overview: lifeway foods - LWAY
LWAY Key Data
| Open $23.93 | Day Range 23.59 - 24.06 |
| 52 Week Range 19.50 - 34.20 | Market Cap $363.82M |
| Shares Outstanding 15.23M | Public Float 5.50M |
| Beta 0.02 | Rev. Per Employee N/A |
| P/E Ratio 33.10 | EPS $0.73 |
| Yield 0.00% | Dividend $0.08 |
| EX-DIVIDEND DATE May 29, 2013 | SHORT INTEREST N/A |
| AVERAGE VOLUME 65.74K |
LWAY Performance
| 1 Week | 1.57% | ||
| 1 Month | -3.17% | ||
| 3 Months | -10.91% | ||
| 1 Year | 1.31% | ||
| 5 Years | 310.96% |
LWAY Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
1
Full Ratings ➔
About lifeway foods - LWAY
Lifeway Foods, Inc. engages in the manufacture of probiotic and nutritious foods. Its products include kefir, organic kefir, plantiful, probugs, frozen kefir, cups and skyr, cheese, and supplements. It distributes its products primarily through its direct sales force, brokers, and distributors. The company was founded by Michael Smolyansky and Ludmila Smolyansky in February 1986 and is headquartered in Morton Grove, IL.
LWAY At a Glance
Lifeway Foods, Inc.
6431 West Oakton Street
Morton Grove, Illinois 60053
| Phone | 1-847-967-1010 | Revenue | 186.82M | |
| Industry | Food: Meat/Fish/Dairy | Net Income | 9.03M | |
| Sector | Consumer Non-Durables | 2024 Sales Growth | 16.673% | |
| Fiscal Year-end | 12 / 2025 | Employees | 291 | |
| View SEC Filings |
LWAY Valuation
| P/E Current | 33.103 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 41.576 |
| Price to Sales Ratio | 2.008 |
| Price to Book Ratio | 5.208 |
| Price to Cash Flow Ratio | 28.95 |
| Enterprise Value to EBITDA | 20.804 |
| Enterprise Value to Sales | 1.92 |
| Total Debt to Enterprise Value | 0.00 |
LWAY Efficiency
| Revenue/Employee | 641,993.127 |
| Income Per Employee | 31,013.746 |
| Receivables Turnover | 11.636 |
| Total Asset Turnover | 2.142 |
LWAY Liquidity
| Current Ratio | 2.813 |
| Quick Ratio | 2.253 |
| Cash Ratio | 1.079 |
LWAY Profitability
| Gross Margin | 25.711 |
| Operating Margin | 7.415 |
| Pretax Margin | 7.477 |
| Net Margin | 4.831 |
| Return on Assets | 10.348 |
| Return on Equity | 13.638 |
| Return on Total Capital | 12.53 |
| Return on Invested Capital | 13.468 |
LWAY Capital Structure
| Total Debt to Total Equity | 0.163 |
| Total Debt to Total Capital | 0.162 |
| Total Debt to Total Assets | 0.127 |
| Long-Term Debt to Equity | 0.097 |
| Long-Term Debt to Total Capital | 0.097 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Lifeway Foods - LWAY
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 119.06M | 141.57M | 160.12M | 186.82M | |
Sales Growth
| +16.70% | +18.90% | +13.11% | +16.67% | |
Cost of Goods Sold (COGS) incl D&A
| 90.48M | 115.32M | 118.22M | 138.79M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 2.87M | 2.97M | 3.16M | 3.39M | |
Depreciation
| 2.75M | 2.43M | 2.62M | 2.85M | |
Amortization of Intangibles
| 122.00K | 540.00K | 540.00K | 540.00K | |
COGS Growth
| +20.24% | +27.46% | +2.51% | +17.39% | |
Gross Income
| 28.59M | 26.25M | 41.90M | 48.03M | |
Gross Income Growth
| +6.75% | -8.19% | +59.65% | +14.64% | |
Gross Profit Margin
| +24.01% | +18.54% | +26.17% | +25.71% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 22.63M | 23.90M | 24.91M | 34.18M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 22.63M | 23.90M | 24.91M | 34.18M | |
SGA Growth
| +3.51% | +5.62% | +4.22% | +37.24% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | - | 83.00K | - |
EBIT after Unusual Expense
| 5.88M | 2.35M | 17.00M | 13.85M | |
Non Operating Income/Expense
| (148.00K) | (241.00K) | 38.00K | 222.00K | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 116.00K | 267.00K | 384.00K | 105.00K | |
Interest Expense Growth
| -1.69% | +130.17% | +43.82% | -72.66% | |
Gross Interest Expense
| 116.00K | 267.00K | 384.00K | 105.00K | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 5.62M | 1.84M | 16.65M | 13.97M | |
Pretax Income Growth
| +16.32% | -67.22% | +804.35% | -16.10% | |
Pretax Margin
| +4.72% | +1.30% | +10.40% | +7.48% | |
Income Tax
| 2.31M | 917.00K | 5.28M | 4.94M | |
Income Tax - Current - Domestic
| 2.05M | 1.09M | 5.31M | 4.88M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| 257.00K | (172.00K) | (28.00K) | 61.00K | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 3.31M | 924.00K | 11.37M | 9.03M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 3.31M | 924.00K | 11.37M | 9.03M | |
Net Income Growth
| +2.44% | -72.09% | +1,130.19% | -20.60% | |
Net Margin Growth
| +2.78% | +0.65% | +7.10% | +4.83% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 3.31M | 924.00K | 11.37M | 9.03M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 3.31M | 924.00K | 11.37M | 9.03M | |
EPS (Basic)
| 0.2131 | 0.06 | 0.775 | 0.6111 | |
EPS (Basic) Growth
| +2.85% | -71.84% | +1,191.67% | -21.15% | |
Basic Shares Outstanding
| 15.54M | 15.40M | 14.67M | 14.77M | |
EPS (Diluted)
| 0.2099 | 0.0588 | 0.7526 | 0.5965 | |
EPS (Diluted) Growth
| +2.39% | -71.99% | +1,179.93% | -20.74% | |
Diluted Shares Outstanding
| 15.77M | 15.72M | 15.10M | 15.13M | |
EBITDA
| 8.84M | 5.32M | 20.16M | 17.24M | |
EBITDA Growth
| +8.26% | -39.78% | +278.82% | -14.48% | |
EBITDA Margin
| +7.42% | +3.76% | +12.59% | +9.23% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 33.00 | |
| Number of Ratings | 1 | Current Quarters Estimate | 0.31 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 1.05 | |
| Last Quarter’s Earnings | 0.23 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.60 | Next Fiscal Year Estimate | 1.33 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 1 | 1 | 1 | 1 |
| Mean Estimate | 0.31 | 0.25 | 1.05 | 1.33 |
| High Estimates | 0.31 | 0.25 | 1.05 | 1.33 |
| Low Estimate | 0.31 | 0.25 | 1.05 | 1.33 |
| Coefficient of Variance | N/A | N/A | N/A | N/A |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 1 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Lifeway Foods - LWAY
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Lifeway Foods - LWAY
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 26, 2025 | Edward P. Smolyansky | 1,245,285 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $26.53 per share | 33,037,411.05 |
| Sep 26, 2025 | Edward P. Smolyansky | 1,235,285 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $26.69 per share | 32,969,756.65 |
| Jun 19, 2025 | Julie Smolyansky CEO, President and Secretary; Director | 2,144,596 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 19, 2025 | Julie Smolyansky CEO, President and Secretary; Director | 2,139,318 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.08 per share | 53,654,095.44 |
| Jun 19, 2025 | Julie Smolyansky CEO, President and Secretary; Director | 12,111 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 19, 2025 | Eric A. Hanson CFO | 42,612 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 19, 2025 | Eric A. Hanson CFO | 41,633 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $25.08 per share | 1,044,155.64 |
| Jun 19, 2025 | Eric A. Hanson CFO | 2,390 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 15, 2025 | Ludmila Smolyansky | 955,823 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.51 per share | 22,471,398.73 |
| Apr 15, 2025 | Ludmila Smolyansky | 940,823 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $23.38 per share | 21,996,441.74 |
| Apr 3, 2025 | Jason Scott Scher Director | 72,118 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 2, 2025 | Julie Smolyansky CEO, President and Secretary; Director | 10,191 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 2, 2025 | Juan Carlos Dalto Director | 461 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 2, 2025 | Eric A. Hanson CFO | 2,228 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |